Iran Conflict Could Feed a Global Defense Boom in 2026
Investors are watching a potential defense-spending surge as the iran conflict could feed new arms orders, lifting de...
Which Aristocrats Etf Grows Best Over 10 Years
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articles
Prices Surge Amid Iran Tensions as Oil Markets Rally
Oil prices surged as tensions with Iran intensified, signaling higher pump costs for consumers. Analysts warn househo...
Phrase Preston Wigner Used Sparks UVV Stock Collapse
Universal Corp misses EPS and swings to a loss in the third quarter, triggering a double-digit stock drop. Analysts f...
Americans’ Opinions on Iran War Split on Escalation
Public sentiment is sharply divided over U.S. action against Iran, with most polls showing more oppose than support. ...
Allogene (ALLO) 2025 Earnings: Milestones and Outlook
As allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
Tether Still Holds More as USDC Surges in Transfer Volume
USDC has overtaken USDT in transfer volume for the first time since 2019, highlighting a shift in how crypto traders ...
Bitcoin Price Prediction: Analyst Warns of Sell the News Trap
Bitcoin hovers near $74,000 as market eyes Powell and the Fed. An analyst warns of a repeat sell-the-news pattern, ev...
Arthur Hayes Bought ETHFI; Upbit Listing Triggers Big Buzz
Former BitMEX chief Arthur Hayes reportedly acquired a tranche of ETHFI ahead of Upbit's listing, sparking a price sp...
BlinkEx Investment Platform Infrastructure in Early Access
BlinkEx rolls out early-access trading focused on robust infrastructure—fast matching, strong risk controls, and reli...
Trump Crypto Ventures Benefit as New Rules Reshape Market
A sweeping regulatory update defines most cryptocurrencies as commodities or digital tools, sparking a rally in crypt...
Iran Rejects Ceasefire Talks as Markets Brace for Tensions
Iran publicly spurns ceasefire talks amid renewed attacks, while the White House insists talks continue. The flare-up...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status